AHA 2024 Insights: Considerations in Care of Patients with Cancer: P…

AHA 2024 Insights

Y. Bryce

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Piedmont Heart Institute

A. Klein

Medical Management of Peripheral Arterial Disease

NY Endovascular Summit

H. Kamran

Perioperative Management of Antithrombotic Therapy

CHEST 2022 Coverage

J. Douketis

Perioperative Considerations for Anticoagulation With Mechanical Dev…

James Douketis

Why Every Physician Must Diagnose Peripheral Artery Disease? How Can…

American Heart & Vascular Institute

S. Khan

Risk Factors and Medical Management of PAD

Jefferson Health

T. Galanis

Clot Chronicles: Peripheral Artery Disease — What Clinicians Should …

The North American Thrombosis Forum (NATF)

M. Mcdermott

PAD and Endovascular Intervention

Complex Coronary Cases

V. Kapur

Anti Platelet Therapy Clinical Case Discussion: Q&A with Dr. Neal Kl…

Houston Methodist DeBakey Heart and Vascular Center

N. Kleiman

Novel Antithrombotics and Antiplatelets in the Treatment of PAD

Marc Bonaca

Anti-platelets in Primary and Secondary Prevention

1st Annual Heart of Prevention Symposium

C. Kliger

Update on Antiplatelet and Antithrombotic Use in Atherosclerosis

NY Endovascular Summit

R. Mehran, A. Lee, P. Krishnan

Medical Management of PAD: Current Data and Recommendations

NY Endovascular Summit

J. Olin

Femoropopliteal Artery Disease and Treatment Options / Literature Re…

NY Endovascular Summit

S. Parikh

Maximal Medical Therapy in Peripheral Arterial Disease

NY Endovascular Summit

D. Kadian-Dodov

Prevention, Protection and Plumbing Key for PAD

Piedmont Heart Institute Napa Valley Cardiology Conference

A. Klein

ESC 2024 Insights: Apixaban vs Clopidogrel on a Background of Aspiri…

ESC 2024 Insights

Treating Peripheral Artery Disease: Beyond Intervention

NY Endovascular Summit

J. Olin